We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Pharmacogenomics Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Overview

Pharmacogenomics is the study of how the genome impacts drug response in different types of animals and people. Its title comes from its combination of genomics and pharmacogenetics. Pharmacogenomics studies how the genetic make-up of an individual impacts their response to various medications. Some examples of drugs that have been studied include cancer drugs, anti-psychotics, and antibiotics, estrogen/progestin used in women, insulin, migraine medications, recreational drugs, and antidepressants. The global pharmacogenomics market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global pharmacogenomics market is expected to witness significant growth during the forecast period, owing to the high rate of adverse drug reactions.

Market Drivers

Growing focus on precision medicine is expected to drive growth of the global pharmacogenomics market during the forecast period. Precision medicine refers to a novel approach to disease treatment and prevention that considers an individual’s lifestyle, environment, and genes. The demand for precision medicine has increased in the recent past as physicians can provide more effective drugs and avoid potential side effects. For instance, in May 2021, AdventHealth partnered with Sema4 to launch a precision medicine program. Hence, such factors are expected to drive growth of the global pharmacogenomics market growth over the forecast period. Moreover, a high rate of adverse drug reactions is expected to propel the global pharmacogenomics market growth over the forecast period.

Market Restraint

Challenges associated with reimbursement and detecting gene variation are expected to hamper the global pharmacogenomics market growth over the forecast period.

Regional Insights

Among regions, North America is expected to witness significant growth in the global pharmacogenomics market during the forecast period. This is owing to a high level of awareness among the general public across the region. Moreover, Asia Pacific is expected to register a robust growth rate, owing to the availability of cheaper infrastructure for R&D projects in India, China, and Japan.

Competitive Section

Major companies involved in the global pharmacogenomics market are Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline.

For instance, in August 2021, GetMyDNA launched Pharmacogenetics (PGx), a consumer-initiated Pharmacogenetics at-home test kit that measures the body’s response to specific drugs.  

Key features of the study:

  • This report provides in-depth analysis of pharmacogenomics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pharmacogenomics market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics
  • The global pharmacogenomics market report caters to various stakeholders in this industry including investors, researchers, pharmacogenomics manufacturers, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the pharmacogenomics market.

Detailed Segmentation:

Global Pharmacogenomics Market, By Technology Type:

Polymerase Chain Reaction

Sequencing
Microarray
Other Technologies

Global Pharmacogenomics Market, By Application:

Drug Discovery
Therapeutic Application


Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Global Pharmacogenomics Market, By Geography:

North America

By Country:

U.S.
Canada

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Asia Pacific

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Latin America

By Country:

Brazil
Mexico
Rest of Latin America

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Middle East

By Country:

GCC
Israel
Rest of Middle East

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application


Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Africa

By Country:

North Africa
Central Africa
South Africa

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application


Oncology
Cardiology
Pain Management
Neurological Disorders
Others


Company Profiles

Thermo Fisher Scientific Inc.*

Company Overview
Technology Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Bayer AG
AstraZeneca plc
Assurex Health
GE Healthcare
Bristol-Myers Squibb Company
Qiagen, Inc.
Hoffmann-La Roche Ltd
Transgenomic, Inc.
Abbott Laboratories, Inc.
GlaxoSmithKline


“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Technology Type
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Supply Side Drivers
o Demand Side Drivers
o Economic Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Epidemiology
o Regulatory Scenario
o Industry Trends
o PEST Analysis
4. Global Pharmacogenomics Market, By Technology Type, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, 2017 - 2025
o Segment Trends
o Polymerase Chain Reaction
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Sequencing
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Microarray
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Other Technologies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Pharmacogenomics Market, By Application, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, 2017 - 2025
o Segment Trends
o Drug Discovery
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Therapeutic Application
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Oncology
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Cardiology
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Pain Management
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Neurological Disorders
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Pharmacogenomics Market, By Regions, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, By Regions, 2017 - 2025
o North America
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o Brazil
o Mexico
o Rest of Latin America
o Africa
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
o Bayer AG
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Thermo Fisher Scientific Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o AstraZeneca plc
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Assurex Health
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GE Healthcare
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Bristol-Myers Squibb Company
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Qiagen, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o F. Hoffmann-La Roche Ltd
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Transgenomic, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Abbott Laboratories, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GlaxoSmithKline
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
8. Section
o References
o Analyst Views
o Research Methodology
o About Us and Sales Contact
*Browse 29 market data tables and 33 figures on "Pharmacogenomics Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.